Shares of Fresenius Medical Care AG (NYSE:FMS - Get Free Report) hit a new 52-week high on Friday . The company traded as high as $25.96 and last traded at $25.67, with a volume of 474236 shares changing hands. The stock had previously closed at $24.73.
Wall Street Analysts Forecast Growth
FMS has been the subject of a number of recent analyst reports. Truist Financial upped their target price on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a "hold" rating in a research report on Monday, January 6th. StockNews.com raised shares of Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 5th.
Read Our Latest Stock Analysis on Fresenius Medical Care
Fresenius Medical Care Stock Performance
The stock has a market cap of $13.60 billion, a P/E ratio of 19.15, a P/E/G ratio of 0.76 and a beta of 0.93. The firm has a 50 day moving average of $24.11 and a two-hundred day moving average of $22.70. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37.
Hedge Funds Weigh In On Fresenius Medical Care
Institutional investors and hedge funds have recently bought and sold shares of the stock. Smartleaf Asset Management LLC grew its position in Fresenius Medical Care by 192.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after purchasing an additional 806 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Fresenius Medical Care in the third quarter valued at about $38,000. Russell Investments Group Ltd. grew its position in Fresenius Medical Care by 234.1% during the fourth quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company's stock worth $71,000 after buying an additional 2,208 shares in the last quarter. Jones Financial Companies Lllp increased its stake in Fresenius Medical Care by 80.5% during the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company's stock valued at $102,000 after acquiring an additional 2,012 shares during the period. Finally, Venturi Wealth Management LLC increased its stake in Fresenius Medical Care by 8.4% during the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock valued at $129,000 after acquiring an additional 441 shares during the period. Institutional investors own 8.37% of the company's stock.
About Fresenius Medical Care
(
Get Free Report)
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Articles
Before you consider Fresenius Medical Care, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care wasn't on the list.
While Fresenius Medical Care currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
